Holen Sie sich die Stockscreener-App
85.67
3.02%
-2.67
Vorhandelsmarkt:
85.80
0.13
+0.15%
Schlusskurs vom Vortag:
$88.34
Offen:
$87.83
24-Stunden-Volumen:
847.93K
Relative Volume:
0.49
Marktkapitalisierung:
$11.50B
Einnahmen:
$3.10B
Nettoeinkommen (Verlust:
$586.71M
KGV:
19.95
EPS:
4.2937
Netto-Cashflow:
$605.57M
1W Leistung:
-0.31%
1M Leistung:
+12.71%
6M Leistung:
-5.43%
1J Leistung:
+41.07%
1-Tages-Spanne:
$85.62
$88.40
1-Wochen-Bereich:
$84.46
$88.89
52-Wochen-Spanne:
$54.15
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
85.67 | 11.86B | 3.10B | 586.71M | 605.57M | 4.2937 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Hochstufung | Needham | Hold → Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2025-11-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-11-07 | Hochstufung | Truist | Hold → Buy |
| 2025-10-28 | Fortgesetzt | Stifel | Hold |
| 2025-05-27 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Globus Medical (NYSE:GMED): A Decent Value Stock With Solid Fundamentals - ChartMill
Globus Medical (GMED) Stock Could Be Undervalued Following Margin Gains Update - Yahoo Finance
Globus Medical Inc (GMED) Stock Down 3.0% -- Now Undervalued? GF Score: 95/100 - GuruFocus
Globus Medical Director Stephen T. Zarrilli Executes Stock Options and Sells Shares on August 18, 2026 - Kalkine Media
Globus Medical Director Sold Shares Worth Over $2.1M - TradingView
Globus Medical (NYSE: GMED) director exercises options, sells 25,000 shares - Stock Titan
Globus Medical: The Dip Makes It Cheaper, Not Different (NYSE:GMED) - Seeking Alpha
Globus Medical: 7 Quarters Of Margin Expansion, Priced For None (NYSE:GMED) - Seeking Alpha
Globus Medical (NYSE: GMED) insider plans $2.2M sale - Stock Titan
Looking for a Growth Stock? 3 Reasons Why Globus Medical (GMED) is a Solid Choice - qz.com
Here is Why Growth Investors Should Buy Globus Medical (GMED) Now - Yahoo Finance
Is Revenue Growth Amid Margin Pressure Altering The Investment Case For Globus Medical (GMED)? - Sahm
Globus Medical (GMED) Stock Analysis: Navigating a 20% Potential Upside with Healthcare Innovation - DirectorsTalk Interviews
Assenagon Asset Management S.A. Sells 127,216 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (GMED) Institutional Ownership 2026 - MarketBeat
Globus Medical Inc (GMED) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Globus Medical (GMED) Stock Sees Modest Fair Value Cut As Analysts Trim Growth Views - Yahoo Finance
Is Globus Medical (GMED) A Bargain On Its Zacks Upgrade And Reaffirmed Guidance? - Yahoo Finance
Globus Medical, Inc. (GMED) Stock Forecasts - Yahoo Finance
Globus Medical (NYSE:GMED) Upgraded at Zacks Research - MarketBeat
Annex Advisory Services LLC Boosts Holdings in Globus Medical, Inc. $GMED - MarketBeat
Q2 2026 Globus Medical, Inc. Earnings Call Transcript - GuruFocus
Nevro, Globus Medical Oppose Bid To Centralize Spinal Cord Stimulator Injury Cases - Mealey's
Globus Medical (GMED) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Bank of America Corp DE Trims Stock Position in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Inc (GMED) Stock Up 4.6% and Still Undervalued -- GF Score: 97/100 - GuruFocus
Is Globus Medical (GMED) Cheap After Its Earnings Beat And Higher EPS Outlook? - Sahm
Globus Medical, Inc. (GMED) Stock Analysis: A Strong Buy With 25% Upside Potential - DirectorsTalk Interviews
Globus Medical, Inc. (NYSE:GMED) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Results: Globus Medical, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Moomoo
Globus Medical Inc Stock Historical Valuations | BSP:G2ME34 - GuruFocus
Oliver Luxxe Assets LLC Boosts Holdings in Globus Medical, Inc. $GMED - MarketBeat
Polianta Ltd Purchases Shares of 21,000 Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Inc (BSP:G2ME34) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Globus Medical Inc Stock Operating Data - GuruFocus
BSP:G2ME34 Dividend: Does Globus Medical Inc Pay a Dividend? - GuruFocus
Globus Medical Inc (BSP:G2ME34) Stock Price & 30 Year Financial Data - GuruFocus
Globus Medical (BSP:G2ME34) Cyclically Adjusted Price-to-FC - GuruFocus
Globus Medical Inc (BSP:G2ME34) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Who's Buying or Selling Globus Medical Inc (BSP:G2ME34) Stock Today? - GuruFocus
Globus Medical Inc Stock Baskets - GuruFocus
Globus Medical Inc (BSP:G2ME34) Stock News, Headlines & Updates - GuruFocus
Globus Medical Inc (BSP:G2ME34) Competitors 2026 - GuruFocus
Globus Medical Inc (BSP:G2ME34) Stock Price, Trades & News - GuruFocus
Globus Medical (NYSE:GMED) Releases Earnings Results, Beats Expectations By $0.24 EPS - MarketBeat
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $85 to $117 - Moomoo
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Artivion (AORT) and Globus Medical (GMED) - theglobeandmail.com
Globus Medical Q2 Earnings Call Highlights - MarketBeat
Globus Medical (NYSE:GMED): A Compelling Affordable Growth Opportunity - ChartMill
Globus Medical (GMED) Stock Leans On Margin Gains As Nevro Recovery Lags - Sahm
GMED Q2 Earnings Call Highlights Margin Gains and Revenue Caution - Yahoo Finance
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):